May 1, 2025 /Mpelembe Media/ — A new online survey conducted by The Harris Poll on behalf of Alkermes, Inc., a biopharmaceutical company focused on neuroscience, explores the experiences of individuals diagnosed with Alcohol Use Disorder (AUD). Continue reading
GammaPod represents a true revolution in the treatment of breast cancer: it allows the safe and precise administration of high doses of radiation to the tumor because, unlike conventional radiotherapy equipment, designed to treat tumors in all areas of the body, GammaPod was invented and designed to treat only breast cancer. Continue reading
A roundup of the most newsworthy healthcare press releases from PR Newswire this week, including the first use of Johnson & Johnson’s robotic surgical system and a staggering global statistic on pediatric antimicrobial resistance. Continue reading
Jan. 23, 2025 /Mpelembe Media/ — A Finnish research project, part of the European ITEA PROFIT initiative, explores using artificial intelligence to alleviate the workload of nurses. The project aims to develop AI tools for tasks like patient registration and information review, freeing up nurses for direct patient care. Continue reading
Jan. 14, 2025 /Mpelembe Media/ — BAIBYS™, an Israeli startup, announced its CE-marked AI-powered robotic system for autonomous sperm selection in IVF. This system uses AI and machine vision to identify and isolate optimal sperm cells, addressing the growing global issue of male infertility. Continue reading
Jan. 6, 2025 /Mpelembe Media/ — , a medical technology company, is partnering with the Mayo Clinic to pilot its Nevisense device in the US. Nevisense, an FDA-approved AI-powered tool, aids in the early detection of melanoma, the deadliest form of skin cancer. Continue reading
Jan. 3, 2025 /Mpelembe Media/ — The Surgeon General of the U.S. has called for cancer warnings on alcoholic beverages, citing studies linking alcohol consumption to at least seven types of cancer. A recent review of research supports this, showing a correlation between higher alcohol intake and increased cancer risk, particularly breast cancer. Continue reading
Jan. 3, 2025 /Mpelembe Media/ — Oncolytics Biotech Inc.’s progress in developing cutting-edge immunotherapies for cancer treatment is the article’s main subject. The piece highlights several key advancements, including clinical trial results and collaborations with other companies. Financial information regarding Oncolytics is included, along with a disclaimer about the nature of the publication. Continue reading
Diseases are best fought when those in the high-risk bracket understand as to what are the risk factors involved. It is true that you cannot avoid the genetic factor but you can still keep the situation in your control by making a few changes in your current approach to life and living. Continue reading
ONE® Flex® Condoms, the world’s first condom enhanced with the wonder material graphene, is now available at select Walmart stores and Walmart.com. Building on its online sales success since its market debut in October 2023, ONE Flex is further expanding its reach by bringing this revolutionary condom technology to Walmart shoppers. Continue reading